These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 6339995
1. [In vitro activity of josamycin in a comparison of Staphylococcus aureus, Streptococcus pyogenes and Streptococcus pneumoniae]. Andreoni O. Minerva Med; 1983 Mar 24; 74(12):619-24. PubMed ID: 6339995 [Abstract] [Full Text] [Related]
3. Susceptibility of Staphylococcus aureus, Streptococcus pyogenes and Diplococcus pneumoniae to antibiotics. Comparison of patterns in Poland and Federal Republic of Germany. Jeljaszewicz J, Stochmal I, Dajek Z, Pulverer G, Hryniewicz W, Cybulska J, Switalski LM, Dziarski R. Zentralbl Bakteriol Orig A; 1976 Aug 24; 235(4):376-85. PubMed ID: 10702 [Abstract] [Full Text] [Related]
6. In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus. Boos M, Mayer S, Fischer A, Köhrer K, Scheuring S, Heisig P, Verhoef J, Fluit AC, Schmitz FJ. Antimicrob Agents Chemother; 2001 Mar 24; 45(3):938-42. PubMed ID: 11181385 [Abstract] [Full Text] [Related]
7. [In vitro examination on antibacterial activity of ciclacillin (ACPC) against clinically isolated strains (author's transl)]. Deguchi K. Jpn J Antibiot; 1977 May 24; 30(5):315-20. PubMed ID: 17021 [Abstract] [Full Text] [Related]
9. Susceptibility to selected antibiotics of Streptococcus pneumoniae and Streptococcus pyogenes strains isolated from patients with respiratory tract infections. Mazur E, Ligieza J, Niedźwiadek J, Polak G, Kozioł-Montewka M, Hencner Z. Ann Univ Mariae Curie Sklodowska Med; 1999 May 24; 54():407-10. PubMed ID: 11205800 [No Abstract] [Full Text] [Related]
14. Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues. Griesgraber G, Kramer MJ, Elliott RL, Nilius AM, Ewing PJ, Raney PM, Bui MH, Flamm RK, Chu DT, Plattner JJ, Or YS. J Med Chem; 1998 May 07; 41(10):1660-70. PubMed ID: 9572891 [Abstract] [Full Text] [Related]
15. In vitro susceptibility studies with josamycin and erythromycin. Strausbaugh LJ, Dilworth JA, Gwaltney JM, Sande MA. Antimicrob Agents Chemother; 1976 Mar 07; 9(3):546-8. PubMed ID: 4012 [Abstract] [Full Text] [Related]
16. [Study on susceptibilities of freshly isolated strains to macrolide antibiotics]. Deguchi K, Yokota N, Koguchi M, Nakane Y, Fukushima Y, Fukayama S, Ishihara R, Oda S, Tanaka S, Sato K. Jpn J Antibiot; 1990 Dec 07; 43(12):2133-41. PubMed ID: 2086825 [Abstract] [Full Text] [Related]
17. In vitro activity of ertapenem against selected respiratory pathogens. Marchese A, Gualco L, Schito AM, Debbia EA, Schito GC. J Antimicrob Chemother; 2004 Nov 07; 54(5):944-51. PubMed ID: 15472001 [Abstract] [Full Text] [Related]
18. Synthesis and antibacterial activity of new 4″-O-carbamates of 11,12-cyclic carbonate erythromycin A 6,9-imino ether. Zhang L, Jiao B, Yang X, Liu L, Ma S. J Antibiot (Tokyo); 2011 Mar 07; 64(3):243-7. PubMed ID: 21245870 [Abstract] [Full Text] [Related]